Patent Applications published on Feb 22, 2024

Explore the 7,633 U.S. Patent Applications published on the 08th week of 2024, including 96 applications that subsequently received a Patent Grant.

Featured patent applications from Feb 22, 2024

Published: 2024-02-22
US20240061515A1
Physics
Application 20240061515, fig. 01

HAND GESTURES FOR ANIMATING AND CONTROLLING VIRTUAL AND GRAPHICAL ELEMENTS

A system has been developed to control virtual elements on a screen using hand gestures captured by a camera in eyewear. The system detects hand shapes and matches them to predefined gestures stored in a library, triggering actions accordingly. For example, making an opening gesture causes graphical elements to move away from a menu icon, while a closing gesture makes them retreat back towards it.

Published: 2024-02-22
US20240064186A1
Electricity
Application 20240064186, fig. 01

MOBILE DEVICE DISPLAYING REAL TIME SPORTS STATISTICS

A mobile device can show live sports stats using a memory and processor. The device gets real-time stats from an outside source and needs to be authenticated. It's a handy tool for keeping up with sports on the go.

Published: 2024-02-22
US20240058380A1
Human necessities
Application 20240058380, fig. 01

CORONA VIRUS-SPECIFIC T CELL RECEPTOR FUSION CONSTRUCTS, VECTORS ENCODING THE SAME, T CELLS COMPRISING THE SAME AND USES THEREOF

A new invention involves a T cell receptor fusion construct that combines specific parts to target the spike protein of coronaviruses, including SARS-CoV-2 and SARS-CoV-1, and ACE2. This construct can be encoded in a vector for modifying T cells to enhance their ability to fight diseases caused by coronaviruses like COVID-19 and SARS. The invention aims to use these modified T cells in treatments for coronavirus-related illnesses.

Published: 2024-02-22
US20240059791A1
Chemistry; metallurgy
Application 20240059791, fig. 01

TRIFUNCTIONAL FUSION PROTEIN CONTAINING TUMOR-ASSOCIATED ANTIGEN (TAA) ANTIBODY AND APPLICATION THEREOF

A new protein has been created that combines a tumor-associated antigen (TAA) antibody, a TGF-β inhibitor, and a CD3 antibody. This protein can target tumors specifically by using the TAA antibody, activate T cells with the CD3 antibody, and enhance T cell activity in the tumor environment by blocking TGF-β signals. The invention aims to improve cancer treatment by utilizing these three functions in one protein.

Published: 2024-02-22
US20240058401A1
Human necessities
Application 20240058401, fig. 01

CANCER IMMUNOTHERAPY USING VIRUS PARTICLES

A new way to treat cancer involves giving a patient a virus or virus-like particle directly into the tumor. This method helps the body's immune system fight against the cancer cells. By using these virus particles, doctors can target and destroy cancer cells more effectively.

Published: 2024-02-22
US20240058516A1
Human necessities
Application 20240058516, fig. 01

FULLY IMPLANTED APHERETER/DIALYZERS FOR INTRACORPOREAL BLOOD PURIFICATION

An implantable device purifies blood inside the body for patients with kidney issues caused by certain blood disorders. It can work continuously or at intervals, reducing the need for frequent clinic visits. The device works with medication to help maintain kidney functions and balance electrolytes, fluids, and nutrients in the blood.

Published: 2024-02-22
US20240060042A1
Chemistry; metallurgy
Application 20240060042, fig. 01

ARTIFICIAL ANTIGEN-PRESENTING CELL

An artificial antigen-presenting cell (aAPC) has been created with immune stimulatory and co-stimulatory ligands to help immune cells grow and multiply. This invention can be used to boost the immune response in the body or treat certain medical conditions. It also includes methods to identify specific antigens or detect immune cells that recognize antigens.

Published: 2024-02-22 Assignee: University of Florida Research Foundation, Incorporation.
US20240060091A1
Chemistry; metallurgy
Application 20240060091, fig. 01

METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D

A method has been developed to control RNA transcript levels using an autoregulated CRISPR-Cas13d system. This system helps regulate the expression and activity of Cas13d, reducing unintended damage to non-target messenger RNA transcripts in cells. It involves a nucleic acid molecule with specific components like a zinc finger binding site, a promoter, and a sequence encoding a Cas13d fusion protein with a transcriptional repressor domain.

Published: 2024-02-22
US20240058384A1
Human necessities
Application 20240058384, fig. 01

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

Chimeric antigen receptors (CARs) are used to target tumor cells that have a specific protein called glypican-3 (GPC3). These CAR-based immunotherapeutic compositions are designed to treat and prevent cancer by attacking the tumor cells. This invention focuses on using CAR technology to fight cancer more effectively.

Published: 2024-02-22
US20240058462A1
Human necessities
Application 20240058462, fig. 01

ARTIFICIAL ANTIGEN-PRESENTING CELLS AND METHODS FOR PRODUCING AND USING THE SAME

These particles mimic cells that help activate T cells in a lab setting. They have special patterns on their surface that resemble the organization of T cell interactions. By using these particles, T cells can be activated for various medical treatments like cancer therapy or autoimmune disease management. Additionally, methods for creating these special particles are also explained.